Related Experiment Video

Updated: Aug 22, 2025

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.6K

Family Health of Patients With Heart Failure and Their Family Members Before and During the First COVID-19 Lockdown

Mahdi Shamali1,2, Hanne Konradsen2,3,4, Birte Østergaard5

  • 1Department of Clinical Research, University of Southern Denmark, Odense, Denmark mshamali62@gmail.com.

Journal of Doctoral Nursing Practice
|November 9, 2022
PubMed

Insights

The COVID-19 lockdown impacted family health in heart failure patients and their families. While overall family health scores remained stable, specific dimensions like values and ill-being showed significant decreases.

Area of Science:

  • Cardiology
  • Public Health
  • Family Medicine

Background:

  • Family health is crucial for self-care and lifestyle adjustments in heart failure management.
  • The first COVID-19 lockdown presented unique challenges to family dynamics and health.
  • Understanding these impacts is vital for holistic patient care.

Purpose of the Study:

  • To examine family health in heart failure patients and their relatives before and during the initial COVID-19 lockdown.
  • To identify changes in family health dimensions influenced by the lockdown environment.

Main Methods:

  • A cross-sectional study design was employed.
  • 34 participants were assessed before the lockdown and 34 during the first COVID-19 lockdown.
  • Independent t-tests were used to compare mean family health scores.

Main Results:

  • No significant difference was found in the total family health scores between pre-lockdown and during-lockdown periods.
  • A significant decrease was observed in the 'values' and 'ill-being' dimensions for patients.
  • The 'ill-being' dimension also significantly decreased for family members during the lockdown.

Conclusions:

  • The COVID-19 lockdown had mixed effects on family health, with some aspects declining.
  • Nurses can utilize these findings to identify families needing targeted support.
  • This research highlights the need for tailored interventions to support family health during public health crises.

Keywords:
COVID-19familyfamily healthheart failure

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

853

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
130
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
27
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37